http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0975591-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9ff2988b0c12145a439b1a8945d0e6d |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D201-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D201-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-36 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D201-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D201-02 |
filingDate | 1998-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3cc4c9f7736ff9a13fd8fa5195218cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1199ca49948e1d9bae56c38efe6d0a39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58621943ddfcbfb764e763d8a0b263c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf38378a14164b59cca78b579026f0a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f159d7da1f4527f2f37670e458cbdd |
publicationDate | 2000-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0975591-A1 |
titleOfInvention | Processes for producing epsilon caprolactams |
abstract | This invention relates in part to processes for producing one or more substituted or unsubstituted epsilon caprolactams, e.g., epsilon caprolactam, which comprises: (a) subjecting one or more substituted or unsubstituted alkadienes to hydroxycarbonylation in the presence of a hydroxycarbonylation catalyst, e.g., a metal-organophosphorus ligand complex catalyst, and neutralization with a base to produce one or more substituted or unsubstituted pentenoic acid salts; (b) subjecting said one or more substituted or unsubstituted pentenoic acid salts to hydroformylation in the presence of a hydroformylation catalyst, e.g., a metal-organophosphorus ligand complex catalyst, to produce one or more substituted or unsubstituted formylvaleric acid salts and/or one or more substituted or unsubstituted epsilon caprolactam precursors; and (c) subjecting said one or more substituted or unsubstituted formylvaleric acid salts and/or said one or more substituted or unsubstituted epsilon caprolactam precursors to reductive amination in the presence of a reductive amination catalyst and cyclization optionally in the presence of a cyclization catalyst to produce said one or more substituted or unsubstituted epsilon caprolactams. This invention also relates in part to reaction mixtures containing one or more substituted or unsubstituted epsilon caprolactams as the principal product(s) of reaction. |
priorityDate | 1997-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 766.